Wegovy, Novo Nordisk and Ozempic
The GLP-1 phenomenon is making the fragmentation and dysfunction of the U.S. health care system even more apparent.
Drugs like Wegovy may trim your waistline but not medical costs, according to an analysis of U.S. health insurance claims ...
The medicines watchdog has revealed that almost 50 patients have been hospitalised “in association with glucagon-like peptide ...
The UK's drug safety regulator is asking doctors to be alert for patients who may be misusing obesity injections, such as ...
Cedars-Sinai experts believe the study's findings can play a crucial role in developing healthcare policies that promote ...
People over 50 who can stand on one leg for 30 seconds are aging gracefully, particularly if it's not their strong leg, a new ...
Lilly will launch its Mounjaro obesity drug in Denmark next week, the U.S. drugmaker said on Thursday, bringing competition ...
Weight-loss jabs are not a quick fix for an “Instagram body”, the Health Secretary has warned. The medicines regulator has ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback